Passing the baton: the HIF switch

Slides:



Advertisements
Similar presentations
Von Hippel-Lindau Syndrome (VHL) Presented by Kelley Montoya March 20, 2003.
Advertisements

Hypoxia Inducible Factor – 1 (HIF-1): A High Impact Factor Free Radical & Radiation Biology College of Medicine The University of Iowa
Insilico design, synthesis and biological evaluation of inhibitors of hypoxia- inducible factor (HIF-1) as antitumor agents Lucía Minini, Maira De Negri,
After a decade of study-ING, a PHD for a versatile family of proteins
Kidney cancer: Identification of novel targets for therapy
Arne R. M. van der Bilt, Elisabeth G. E
Angiogenesis and hepatocellular carcinoma
Volume 76, Issue 9, Pages (November 2009)
HIF1a Pathway ProteinLounge.com Glucose Glucose Glucose Transporter
HIFs: a-cute answer to inflammation?
Prolyl‐hydroxylase‐domain proteins regulate hypoxia inducible factor‐α in response to O2 availability. Prolyl‐hydroxylase‐domain proteins regulate hypoxia.
Louise E. Glover, Sean P. Colgan  Gastroenterology 
Ian M. Adcock, PhD, Kittipong Maneechotesuwan, MD, Omar Usmani, MBBS 
Warren S. Pear, M. Celeste Simon  Cancer Cell 
Regulation of transcription: from lambda to eukaryotes
Sirtuins and the Metabolic Hurdles in Cancer
Tendon Homeostasis: The Right Pull
Esther Bridges, Adrian L. Harris  Cancer Cell 
The VHL/HIF oxygen-sensing pathway and its relevance to kidney disease
A Big Step for SIRT7, One Giant Leap for Sirtuins… in Cancer
PK-M2 Makes Cells Sweeter on HIF1
Stealing VEGF from Thy Neighbor
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Hamid R. Rezvani, Nsrein Ali, Lars J
Hypoxia inducible factors in liver disease and hepatocellular carcinoma: Current understanding and future directions  Garrick K. Wilson, Daniel A. Tennant,
A New Twist in Smad Signaling
Angiogenesis and hepatocellular carcinoma
Understanding the Importance of Smart Drugs in Renal Cell Carcinoma
Volume 76, Issue 9, Pages (November 2009)
Ahmed Mohyeldin, Tomás Garzón-Muvdi, Alfredo Quiñones-Hinojosa 
Making Sense of Intrinsically Disordered Proteins
Hypoxia-Inducible Factors, Stem Cells, and Cancer
Hypoxia-inducible factor pathway and diseases of the vascular wall
Y. Henrotin, Ph.D., B. Kurz, Ph.D., T. Aigner, M.D.DSc. 
Hypoxia: Signaling the Metastatic Cascade
Volume 70, Issue 7, Pages (October 2006)
Volume 107, Issue 1, Pages 1-3 (October 2001)
Regulation of Angiogenesis by Oxygen and Metabolism
Into Thin Air: How We Sense and Respond to Hypoxia
Volume 70, Issue 10, Pages (November 2006)
Molecular Mechanisms Regulating Hair Follicle Development
Proteins Kinases: Chromatin-Associated Enzymes?
SRC and STAT Pathways Journal of Thoracic Oncology
Volume 49, Issue 1, Pages 1-3 (January 2013)
Blinded by the Light: The Growing Complexity of p53
Insight from the Air–Skin Interface
Volume 19, Issue 5, Pages (September 2005)
John D. Gordan, Craig B. Thompson, M. Celeste Simon  Cancer Cell 
Mutations of von Hippel-Lindau Tumor-Suppressor Gene and Congenital Polycythemia  Yves Pastore, Katerina Jedlickova, Yongli Guan, Enli Liu, James Fahner,
Endothelial Cells Form a Phalanx to Block Tumor Metastasis
The Expanding Cosmos of Nuclear Receptor Coactivators
Separating the Good and Evil of Cardiac Growth by CIB1 and Calcineurin
Volume 78, Issue 1, Pages (July 2010)
Angiotensin II: breathtaking in the renal medulla
Inflammation and hypoxia in the kidney: friends or foes?
RelA Life and Death Decisions
Hypoxia and fibrosis in chronic kidney disease: crossing at pericytes
Volume 76, Issue 5, Pages (September 2009)
Transcriptional control of adipocyte formation
PK-M2 Makes Cells Sweeter on HIF1
Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases  Xiaoyu Hu, Lionel B. Ivashkiv  Immunity 
Immunity, Inflammation, and Cancer
ROS: Really involved in Oxygen Sensing
Transcription Dynamics
Notch signaling from tumor cells: A new mechanism of angiogenesis
O2 Sensing: Only Skin Deep?
Tenets of PTEN Tumor Suppression
Christopher G. Abraham, Joaquín M. Espinosa  Cancer Cell 
Update on glucocorticoid action and resistance
No Driver behind the Wheel? Targeting Transcription in Cancer
Presentation transcript:

Passing the baton: the HIF switch Mei Yee Koh, Garth Powis  Trends in Biochemical Sciences  Volume 37, Issue 9, Pages 364-372 (September 2012) DOI: 10.1016/j.tibs.2012.06.004 Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 1 The structural domains of hypoxia-inducible factor (HIF)-1/2/3α and their transcriptional binding partner, HIF-1β/ARNT (aryl hydrocarbon nuclear translocator), that together form the HIF-1, HIF-2 and HIF-3 transcriptional complexes, respectively. The basic helix–loop–helix (bHLH) and per-Arnt-SIM (PAS) domains are involved in DNA binding and heterodimerization; the oxygen-dependent degradation (ODD) domain is required for oxygen-dependent hydroxylation and degradation; and the N-terminal and C-terminal transactivation domains (TAD-N and TAD-C, respectively) are required for transcriptional activation. The binding domains of known modulators of HIF-α are depicted, along with the effects of these interactions on activity of the HIF transcriptional complex (red font indicates inhibitory interactions, green font indicates activating interactions). The von Hippel–Lindau protein (pVHL) E3 ligase complex regulates the oxygen-dependent degradation of all three major HIF-α subunits. Factor inhibiting HIF-1 (FIH-1) hydroxylates HIF-2α at a lower efficiency (broken oval) than HIF-1α (unbroken oval). Receptor for activated protein kinase C 1 (RACK1) promotes the degradation of HIF-1α when heat shock protein (Hsp)90 is inhibited, such as by Hsp90 inhibitors. The hypoxia-associated factor (HAF) selectively binds to HIF-1α and HIF-2α, mediating degradation and transactivation, respectively. Hsp70 promotes the binding of carboxyl terminus of Hsp70-interacting protein (CHIP) to HIF-1α, resulting in HIF-1α degradation. Sirtuin 1 (SIRT1) deacetylates HIF-2α, resulting in activation. Trends in Biochemical Sciences 2012 37, 364-372DOI: (10.1016/j.tibs.2012.06.004) Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 2 The transition from hypoxia-inducible factor (HIF)-1- to HIF-2-dependent transcription is dependent on oxygen tension during vascular and bone development. (a) HIF-1 plays a dominant role during vasculogenesis (i), which occurs under intense hypoxia. Although both HIF-1 and HIF-2 play complementary roles during angiogenesis (ii), the final stages of vascular remodeling and stabilization (iii, iv), such as pericyte (pct) and smooth muscle cell (smc) recruitment, occur under less hypoxic conditions and are mainly HIF-2 driven. HIF target genes involved in the various stages of vascular development are indicated in italics. (b) During the initial stage of bone development, HIF-1 is required for mesenchymal cell condensation, chondrocyte proliferation, and synthesis of the cartilaginous extracellular matrix (ECM) (i). Next, proliferation continues to be promoted by HIF-1, whereas cells within the hypertrophic zone require HIF-2 to undergo hypertrophic differentiation (ii). This is followed by vascular invasion of the hypertrophic zone, which requires both HIF-1 and HIF-2 (iii). Finally, degradation of cartilage and its eventual replacement with bone is promoted by HIF-2 (iv). Major HIF target genes are indicated in italics. Trends in Biochemical Sciences 2012 37, 364-372DOI: (10.1016/j.tibs.2012.06.004) Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 3 The switch from hypoxia-inducible factor (HIF)-1- to HIF-2-dependent transcription during chronic hypoxia in solid tumors. (a) The diffusion limitation of oxygen results in oxygen gradients within solid tumors (i). Acute hypoxia caused by vessel occlusion or rapid tumor growth promotes induction of both HIF-1α and HIF-2α (ii); however, HIF-1 is the major driver of the acute response. This causes activation of the HIF-1 transcriptional program, which promotes alleviation of hypoxia through angiogenesis and/or reperfusion, or (iii) cell death (broken circles), depending on the mutational landscape of the tumor cells. Alternatively, chronic hypoxia (iv) can increase hypoxia-associated factor (HAF) and HIF-2α levels, mediating a switch to HIF-2-dependent transcription that promotes tumor adaptation, proliferation and progression. (b) The temporal regulation of HIF-1α (blue line), HIF-2α (green line) and HAF (red line) in response to prolonged hypoxic exposure. The window in which the HIF-1α to HIF-2α switch occurs is indicated by broken vertical lines. Trends in Biochemical Sciences 2012 37, 364-372DOI: (10.1016/j.tibs.2012.06.004) Copyright © 2012 Elsevier Ltd Terms and Conditions